Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Sep 14, 2014; 20(34): 12171-12181
Published online Sep 14, 2014. doi: 10.3748/wjg.v20.i34.12171
Published online Sep 14, 2014. doi: 10.3748/wjg.v20.i34.12171
Figure 3 Immunocytochemistry for KL-6/MUC1 expression in Panc-1 and Capan-1 cells.
Staining for KL-6/MUC1 in A-C: Panc-1; or D-F: Capan-1 cells. A, D: Controls; B, E: 48 h treatment with 2.0 mg% tunicamycin; C, F: 48 h treatment with 5.0 mmol/L benzyl-N-acetyl-α-galactosaminide (800 × magnification).
- Citation: Xu HL, Zhao X, Zhang KM, Tang W, Kokudo N. Inhibition of KL-6/MUC1 glycosylation limits aggressive progression of pancreatic cancer. World J Gastroenterol 2014; 20(34): 12171-12181
- URL: https://www.wjgnet.com/1007-9327/full/v20/i34/12171.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i34.12171